Carcinoma in situ of skin of right lower eyelid, including canthus
ICD-10 D04.112 is a billable code used to indicate a diagnosis of carcinoma in situ of skin of right lower eyelid, including canthus.
Carcinoma in situ (CIS) of the skin is a non-invasive form of cancer that is confined to the epidermis, the outermost layer of skin. In the case of D04.112, this condition specifically affects the right lower eyelid, including the canthus, which is the corner of the eye where the upper and lower eyelids meet. CIS is characterized by the presence of abnormal cells that have the potential to develop into invasive cancer if left untreated. The right lower eyelid is particularly sensitive due to its thin skin and proximity to the eye, making early detection and treatment crucial. Surveillance protocols typically involve regular dermatological examinations to monitor for changes in the lesion, as well as patient education on self-examination techniques. The risk of progression to invasive carcinoma is present, especially in patients with a history of skin cancer or significant sun exposure. Treatment options may include surgical excision, cryotherapy, or topical chemotherapy, depending on the size and characteristics of the lesion. Regular follow-up is essential to ensure that any recurrence or new lesions are promptly addressed.
Detailed descriptions of the lesion, including size, color, and any changes over time.
Diagnosis of CIS during routine skin checks, treatment planning for excision.
Ensure that all findings are documented in the patient's chart to support the diagnosis and treatment plan.
Documentation of ocular health, potential impact on vision, and any surgical interventions performed.
Referral for surgical excision of eyelid lesions, monitoring for ocular complications.
Collaboration with dermatology for comprehensive care and documentation of the ocular implications of the lesion.
Used when excising a CIS lesion from the right lower eyelid.
Operative report detailing the excision and pathology results.
Dermatology and ophthalmology must coordinate documentation for surgical procedures.
Accurate coding of D04.112 is crucial for ensuring appropriate treatment and follow-up care for patients with carcinoma in situ, as it helps in monitoring progression and preventing invasive cancer.
